Full Papers
Juvenile, adult and late-onset systemic lupus erythematosus: a long term follow-up study from a geographic and ethnically homogeneous population
J. Martínez-Barrio1, J.G. Ovalles-Bonilla2, F.J. López-Longo3, C.M. González4, M. Montoro5, L. Valor6, L.P. Martínez7, J.C. Nieto8, M.C. Hinojosa-Dávila9, N. Bello10, I. Monteagudo11, E. Naredo12, L. Carreño13
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain. juliamartinezbarrio@gmail.com
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital; and Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Unit of Paediatric Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital, Madrid, Spain.
- Department of Rheumatology, Gregorio Marañón General Hospital; and Facultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain.
CER7874
2015 Vol.33, N°6
PI 0788, PF 0794
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 26575830 [PubMed]
Received: 29/08/2014
Accepted : 23/03/2015
In Press: 17/11/2015
Published: 15/12/2015
Abstract
OBJECTIVES:
This paper aims to identify clinical and serological differences, damage accrual and mortality, in juvenile, adult and late-onset SLE.
METHODS:
We conducted our study with patients fulfilling SLE classification criteria taken from the Hospital Gregorio Marañon Autoimmune Systemic Rheumatic Diseases’ Registry (1986 to 2012). Clinical characteristics, laboratory data and therapies used during the course of the disease were analysed with patients divided into 3 groups: juvenile-onset (≤18 years), adult-onset (19-50) and late onset (>50 years).
RESULTS:
Four hundred and forty-five patients were included. Renal disease and cutaneous manifestations were more frequent in the juvenile-onset group at disease onset. During follow-up, juvenile-onset group presented a higher incidence of renal disease, malar rash, Raynaud’s phenomenon, cutaneous vasculitis, and neuropsychiatric manifestations than the other two groups. Arthritis and lymphopoenia were more frequent in the adult-onset group. Arterial hypertension and neoplasm were more frequent in the late-onset group. Low serum complement, anti-dsDNA, anti-U1RNP and anti-Sm antibodies were more common in the juvenile-onset group. Patients with late-onset SLE had more damage accrual. Thirty-seven patients (8.3%) died during the study. All-cause mortality was significantly higher in the late-onset group. Age at disease onset >50 years was an independent risk factor for damage accrual (OR, 2.2; 95%CI, 1.1–4.6; p=0.029) and mortality (OR, 2.6; 95%CI, 1.1-6.3; p=0.03).
CONCLUSIONS:
We found significant differences in clinical and serological profiles between juvenile, adult and late-onset SLE. The most significant of which was a higher prevalence of neuropsychiatric and renal complications as well as different autoantibody signatures for the juvenile-onset group.
